Close Menu

NEW YORK (GenomeWeb) – CareDx said today that its preliminary fourth quarter revenues rose 85 percent to 88 percent year over year, thanks to an increase of about 115 percent in testing revenues during the quarter.

For the three months ended Dec. 31, 2018, the company expects revenues of $23.2 million to $23.5 million, compared with $12.5 million in the fourth quarter of 2017. Analysts are expecting revenues of $21.8 million for the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.